Holen Sie sich die Stockscreener-App
8.825
2.55%
0.195
Finanzdaten der Diamedica Therapeutics Inc-Aktie (DMAC)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Research and Development |
2.93%
5.822
|
5.656 | 6.47 | 4.983 | 3.928 |
| Operating Income/Loss |
1.68%
-8.007
|
-8.144 | -8.419 | -6.883 | -5.638 |
| Nonoperating Income/Loss |
29.12%
0.314
|
0.443 | - | - | - |
| Income/Loss From Continuing Operations Before Tax |
0.10%
-7.693
|
-7.701 | -7.891 | -6.267 | -5.112 |
| Income Tax Expense/Benefit |
0.00%
0.006
|
0.006 | 0.009 | 0.007 | 0.007 |
| Income/Loss From Continuing Operations After Tax |
0.10%
-7.699
|
-7.707 | -7.90 | -6.274 | -5.119 |
Net Income/Loss
|
0.10%
-7.699
|
-7.707 | -7.90 | -6.274 | -5.119 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.27%
42.96
|
42.84 | 0.8005 | 42.75 | 38.07 |
| Basic Earnings Per Share |
0.00%
-0.18
|
-0.18 | -0.18 | -0.15 | -0.13 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.49%
2.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):